Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:

Coronavirus digest: US to launch trade talks on vaccine distribution | DW |

"Intellectual property rights is part of the problem. But really, manufacturing is the biggest problem.

We have a factory here in the US that has the full intellectual property rights to make the vaccine. They aren't making doses because the factory has problems."

Pfizer/BioNTech Vaccine Not Yet Approved

Pfizer said it is in talks with the Indian government over an "expedited approval pathway" for its COVID-19 vaccine.

"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," Pfizer CEO Albert Bourla said.

"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."



'Sapere aude'
by Oui (Oui) on Mon May 3rd, 2021 at 02:11:44 PM EST

Others have rated this comment as follows:

Display:

Occasional Series